Singapore Warns of ‘Urgent’ Job Loss Challenge in Year Ahead
(Bloomberg) -- One of Singapore's top political leaders said the city-state faces a “major and urgent challenge” in the next six months to a year, warning of more job losses ahead amid the coronavirus outbreak.
The comments from Tharman Shanmugaratnam came after he chaired the first meeting for a council that included business groups and government leaders to seek new job opportunities to cope with the slowdown. About 100,000 jobs, both permanent and temporary, and training opportunities could be created from that initiative, he said.
“But we have to be realistic,” the senior minister and coordinating minister for social policies said in a Facebook post. The “sheer uncertainty” in the global economy means “we will have far fewer new job openings than jobs being lost -- over the next year, and beyond that if we are unlucky,” he said.
Singapore's approach to the virus is set to become a defining issue in upcoming elections, with lockdown curbs set to drag on past most of Asia's after its original, less restrictive approach was scuppered by a second wave of infections.
Singapore's Long Lockdown Challenges Leaders Facing Election
The city-state, which began easing some of the restrictions this week to restart its economy, is trying to prevent another resurgence in virus cases after an outbreak centered on its army of low-waged migrant workers sent cases above 36,000. Still, it has one of the lowest death rates with just 24 fatalities, and only a handful of patients remain in intensive care.
The senior minister also cautioned against a situation in countries where a jobless rate of 10% or more becomes a new normal for both the government and people.
“No amount of unemployment benefits can compensate for not having a job, and for the social stagnation and loss of optimism about the future that comes when a large segment of the population feels redundant and out of sorts,” he said. “We must never get there.”
Singapore Focuses on Jobs in New S$33 Billion Virus Relief
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.